In the present study, we measured copy number of members of ErbB family (including EGFR, HER2, HER3 and HER4) in a cohort of glioma patients and control subjects using real-time qPCR approach and determined their prognostic significance in gliomas. This evidence concerns the gene ERBB3 and central nervous system cancer.